Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Atish D Choudhury

Showing results (11-20 of 69) with videos related to

Pageof 7
Sort By:
Cancers|June 12, 2026
Circulating Tumor DNA as Emerging Predictive and Prognostic Biomarker in Prostate CancerBicky Thapa, Jacopo Venturini, Atish D Choudhury, et al.
Clinical Nuclear Medicine|December 18, 2023
Late Subacute Cerebral Hematoma Mimicking a Metastasis on PSMA PET/CTNuno Vaz, Eric Dietsche, Michael A Mooney, et al.
The Journal of Biological Chemistry|April 28, 2005
Hyperphosphorylation of the BARD1 tumor suppressor in mitotic cellsAtish D Choudhury, Hong Xu, Ami P Modi, et al.
CA: a Cancer Journal for Clinicians|November 9, 2020
Circulating tumor DNA in advanced solid tumors: Clinical relevance and future directionsMichael L Cheng, Eirini Pectasides, Glenn J Hanna, et al.
Prostate Cancer and Prostatic Diseases|February 11, 2022
Outcomes in men with metastatic castration-resistant prostate cancer who received sipuleucel-T and no immediate subsequent therapy: experience at Dana Farber and in the PROCEED RegistryXiao X Wei, Lucia Kwak, Anis Hamid, et al.
World Journal of Urology|November 4, 2023
MR-guided prostate SBRT in prostate cancer patients with low-volume metastatic diseaseShalini Moningi, Atish D Choudhury, Neil E Martin, et al.
NPJ Precision Oncology|June 29, 2022
PALB2 or BARD1 loss confers homologous recombination deficiency and PARP inhibitor sensitivity in prostate cancerKasia M Dillon, Raie T Bekele, Zsofia Sztupinszki, et al.
European Urology|June 15, 2012
The role of genetic markers in the management of prostate cancerAtish D Choudhury, Rosalind Eeles, Stephen J Freedland, et al.
Prostate Cancer and Prostatic Diseases|November 18, 2025
Publisher Correction: Testosterone suppression and recovery with abiraterone/prednisone monotherapy after early discontinuation of LHRH-A in hormone sensitive prostate cancerAutumn Gagnon, Caiwei Zhong, Wanling Xie, et al.
Prostate Cancer and Prostatic Diseases|October 28, 2025
Testosterone suppression and recovery with abiraterone/prednisone monotherapy after early discontinuation of LHRH-A in hormone sensitive prostate cancerAutumn Gagnon, Caiwei Zhong, Wanling Xie, et al.
Pageof 7

Showing results (11-20 of 69) with videos related to

Sort By:
Pageof 7
Cancers|June 12, 2026
Circulating Tumor DNA as Emerging Predictive and Prognostic Biomarker in Prostate CancerBicky Thapa, Jacopo Venturini, Atish D Choudhury, et al.
Clinical Nuclear Medicine|December 18, 2023
Late Subacute Cerebral Hematoma Mimicking a Metastasis on PSMA PET/CTNuno Vaz, Eric Dietsche, Michael A Mooney, et al.
The Journal of Biological Chemistry|April 28, 2005
Hyperphosphorylation of the BARD1 tumor suppressor in mitotic cellsAtish D Choudhury, Hong Xu, Ami P Modi, et al.
CA: a Cancer Journal for Clinicians|November 9, 2020
Circulating tumor DNA in advanced solid tumors: Clinical relevance and future directionsMichael L Cheng, Eirini Pectasides, Glenn J Hanna, et al.
Prostate Cancer and Prostatic Diseases|February 11, 2022
Outcomes in men with metastatic castration-resistant prostate cancer who received sipuleucel-T and no immediate subsequent therapy: experience at Dana Farber and in the PROCEED RegistryXiao X Wei, Lucia Kwak, Anis Hamid, et al.
World Journal of Urology|November 4, 2023
MR-guided prostate SBRT in prostate cancer patients with low-volume metastatic diseaseShalini Moningi, Atish D Choudhury, Neil E Martin, et al.
NPJ Precision Oncology|June 29, 2022
PALB2 or BARD1 loss confers homologous recombination deficiency and PARP inhibitor sensitivity in prostate cancerKasia M Dillon, Raie T Bekele, Zsofia Sztupinszki, et al.
European Urology|June 15, 2012
The role of genetic markers in the management of prostate cancerAtish D Choudhury, Rosalind Eeles, Stephen J Freedland, et al.
Prostate Cancer and Prostatic Diseases|November 18, 2025
Publisher Correction: Testosterone suppression and recovery with abiraterone/prednisone monotherapy after early discontinuation of LHRH-A in hormone sensitive prostate cancerAutumn Gagnon, Caiwei Zhong, Wanling Xie, et al.
Prostate Cancer and Prostatic Diseases|October 28, 2025
Testosterone suppression and recovery with abiraterone/prednisone monotherapy after early discontinuation of LHRH-A in hormone sensitive prostate cancerAutumn Gagnon, Caiwei Zhong, Wanling Xie, et al.
Pageof 7